<table class="drug-table data-table table table-condensed table-bordered"><tbody><tr id="identification"><th class="divider" colspan="2">Identification</th></tr><tr><th>Name</th><td><strong>Timolol</strong></td></tr><tr><th>Accession Number</th><td><strong>DB00373</strong>&#160; (APRD00229, DB08625)</td></tr><tr><th>Type</th><td>small molecule</td></tr><tr><th>Groups</th><td>approved</td></tr><tr><th>Description</th><td><p>A beta-adrenergic antagonist similar in action to propranolol. The levo-isomer is the more active. Timolol has been proposed as an antihypertensive, antiarrhythmic, antiangina, and antiglaucoma agent. It is also used in the treatment of migraine disorders and tremor. [PubChem]</p></td></tr><tr><th>Structure</th><td><div class="structure"><a class="moldbi-thumbnail" href="http://structures.wishartlab.com/molecules/DB00373/image.png"><img alt="Thumb" src="http://structures.wishartlab.com/molecules/DB00373/thumb.png"></a></div><div class="structure-links"><div class="btn-group btn-group-xs"><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00373.mol">MOL</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00373.sdf">SDF</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00373.pdb">PDB</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00373.smiles">SMILES</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00373.inchi">InChI</a><a class="btn btn-info" href="/structures/structures/small_molecule_drugs/DB00373">View Structure</a></div></div></td></tr><tr><th>Synonyms</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="synonyms"><thead><th>Synonym</th><th>Language</th><th>Code</th></thead><tbody><tr><td>(S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol</td><td><span class="wishart wishart-not-available">Not Available</span></td><td>IUPAC</td></tr><tr><td>Timolol</td><td>French/German/Spanish</td><td>BAN, DCF, USAN</td></tr><tr><td>Timololo</td><td><span class="wishart wishart-not-available">Not Available</span></td><td>DCIT</td></tr><tr><td>Timololum</td><td>Latin</td><td>INN</td></tr></tbody></table></td></tr><tr><th>Salts</th><td class="table-container"><table class="inner">
  <thead>
    <tr>
      <th>Name/CAS</th>
      <th>Structure</th>
      <th>Properties</th>
      <th></th>
    </tr>
  </thead>
  <tbody>
      <tr>
        <td>
          <strong>Timolol hemihydrate</strong>
          <div class="cas"></div>
        </td>
        <td><a class="moldbi-thumbnail" href="http://structures.wishartlab.com/molecules/DBSALT000990/image.png"><img alt="Thumb" src="http://structures.wishartlab.com/molecules/DBSALT000990/thumb.png"></a></td>
        <td>
            <span class="wishart wishart-not-available">Not applicable</span>
        </td>
        <td><a class="btn btn-default btn-xs" href="/salts/DBSALT000990">DBSALT000990</a></td>
      </tr>
      <tr>
        <td>
          <strong>Timolol maleate</strong>
          <div class="cas"></div>
        </td>
        <td><a class="moldbi-thumbnail" href="http://structures.wishartlab.com/molecules/DBSALT000989/image.png"><img alt="Thumb" src="http://structures.wishartlab.com/molecules/DBSALT000989/thumb.png"></a></td>
        <td>
            <span class="wishart wishart-not-available">Not applicable</span>
        </td>
        <td><a class="btn btn-default btn-xs" href="/salts/DBSALT000989">DBSALT000989</a></td>
      </tr>
  </tbody>
</table></td></tr><tr><th>Brand names</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="brands"><thead><tr><th>Name</th><th>Company</th></tr></thead><tbody><tr><td>Betimol</td><td>Santen</td></tr><tr><td>Blocadren</td><td>Merck</td></tr><tr><td>Istalol</td><td>Ista</td></tr><tr><td>Proflax</td><td>Sidus</td></tr><tr><td>Tenopt</td><td>Sigma</td></tr><tr><td>Timacar Depot</td><td>MSD</td></tr><tr><td>Timacor</td><td>Gerda</td></tr><tr><td>Timoptic</td><td>Aton</td></tr><tr><td>Timoptic-XE</td><td>Merck Frosst</td></tr><tr><td>Timoptol</td><td>Merck</td></tr></tbody></table></td></tr><tr><th>Brand mixtures</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="mixtures"><thead><tr><th>Brand Name</th><th>Ingredients</th></tr></thead><tbody><tr><td>Aliviapres</td><td>Timolol and Dorzolamide</td></tr><tr><td>Combigan</td><td>Brimonidine Tartrate + Timolol Maleate</td></tr><tr><td>Cosopt</td><td>Dorzolamide Hydrochloride + Timolol Maleate</td></tr><tr><td>DuoTrav</td><td>Timolol + Travoprost</td></tr><tr><td>Timolide Tab</td><td>Hydrochlorothiazide + Timolol Maleate</td></tr><tr><td>Timpilo 2</td><td>Pilocarpine Hydrochloride + Timolol Maleate</td></tr><tr><td>Timpilo 4</td><td>Pilocarpine Hydrochloride + Timolol Maleate</td></tr><tr><td>Xalacom</td><td>Latanoprost + Timolol Maleate</td></tr></tbody></table></td></tr><tr><th>Categories</th><td><ul><li><a href="/mesh/antihypertensive-agents">Antihypertensive Agents</a></li>
<li><a href="/mesh/anti-arrhythmia-agents">Anti-Arrhythmia Agents</a></li>
<li><a href="/mesh/adrenergic-beta-antagonists">Adrenergic beta-Antagonists</a></li></ul></td></tr><tr><th>CAS number</th><td>26839-75-8</td></tr><tr><th>Weight</th><td>Average: 316.42<br>Monoisotopic: 316.156911344</td></tr><tr><th>Chemical Formula</th><td>C<sub>13</sub>H<sub>24</sub>N<sub>4</sub>O<sub>3</sub>S</td></tr><tr><th>InChI Key</th><td>BLJRIMJGRPQVNF-UHFFFAOYSA-N</td></tr><tr><th>InChI</th><td><div class="wrap">InChI=1S/C13H24N4O3S/c1-13(2,3)14-8-10(18)9-20-12-11(15-21-16-12)17-4-6-19-7-5-17/h10,14,18H,4-9H2,1-3H3</div></td></tr><tr><th>IUPAC Name</th><td><div class="wrap">tert-butyl(2-hydroxy-3-{[4-(morpholin-4-yl)-1,2,5-thiadiazol-3-yl]oxy}propyl)amine</div></td></tr><tr><th>SMILES</th><td><div class="wrap">CC(C)(C)NCC(O)COC1=NSN=C1N1CCOCC1</div></td></tr><tr><th>Mass Spec</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="taxonomy"><th class="divider" colspan="2">Taxonomy</th></tr><tr><th>Kingdom</th><td>Organic Compounds</td></tr><tr><th>Superclass</th><td>Organooxygen Compounds</td></tr><tr><th>Class</th><td>Ethers</td></tr><tr><th>Subclass</th><td>Alkyl Aryl Ethers</td></tr><tr><th>Direct parent</th><td>Alkyl Aryl Ethers</td></tr><tr><th>Alternative parents</th><td>Morpholines; Aminothiadiazoles; Tertiary Amines; 1,2-Aminoalcohols; Secondary Alcohols; Dialkylamines; Polyamines</td></tr><tr><th>Substituents</th><td>3-amino-1,2,5-thiadiazole; oxazinane; morpholine; thiadiazole; azole; tertiary amine; secondary alcohol; 1,2-aminoalcohol; secondary amine; secondary aliphatic amine; polyamine; alcohol; organonitrogen compound; amine</td></tr><tr><th>Classification description</th><td>This compound belongs to the alkyl aryl ethers. These are organic compounds containing the alkyl aryl ether functional group with formula R-O-R' , where R is an alkyl group and R' is an aryl group.</td></tr><tr id="pharmacology"><th class="divider" colspan="2">Pharmacology</th></tr><tr><th>Indication</th><td>In its oral form it is used to treat high blood pressure and prevent heart attacks, and occasionally to prevent migraine headaches. In its opthalmic form it is used to treat open-angle and occasionally secondary glaucoma.</td></tr><tr><th>Pharmacodynamics</th><td>Similar to propranolol and nadolol, timolol is a non-selective, beta-adrenergic receptor antagonist. Timolol does not have significant intrinsic sympathomimetic, direct myocardial depressant, or local anesthetic (membrane-stabilizing) activity, but does possess a relatively high degree of lipid solubility. Timolol, when applied topically to the eye, has the action of reducing elevated, as well as normal, intraocular pressure, whether or not accompanied by glaucoma. Elevated intraocular pressure is a major risk factor in the pathogenesis of glaucomatous visual field loss and optic nerve damage.</td></tr><tr><th>Mechanism of action</th><td>Like propranolol and nadolol, timolol competes with adrenergic neurotransmitters such as catecholamines for binding at beta(1)-adrenergic receptors in the heart and vascular smooth muscle and beta(2)-receptors in the bronchial and vascular smooth muscle. Beta(1)-receptor blockade results in a decrease in resting and exercise heart rate and cardiac output, a decrease in both systolic and diastolic blood pressure, and, possibly, a reduction in reflex orthostatic hypotension. Beta(2)-blockade results in an increase in peripheral vascular resistance. The exact mechanism whereby timolol reduces ocular pressure is still not known. The most likely action is by decreasing the secretion of aqueous humor.</td></tr><tr><th>Absorption</th><td>Bioavailability is about 60%</td></tr><tr><th>Volume of distribution</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Protein binding</th><td>~10%</td></tr><tr><th>Metabolism</th><td class="data-table-container"><p>Primarily hepatic (80%) via the cytochrome P450 2D6 isoenzyme.</p></td></tr><tr><th>Route of elimination</th><td>Timolol and its metabolites are primarily excreted in the urine.</td></tr><tr><th>Half life</th><td>2.5-5 hours</td></tr><tr><th>Clearance</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Toxicity</th><td>LD<sub>50</sub>=1190 mg/kg (oral, mice), LD<sub>50</sub>=900 mg/kg (oral, rat). Symptoms of overdose include drowsiness, vertigo, headache, and atriventricular block.</td></tr><tr><th>Affected organisms</th><td><ul><li>Humans and other mammals</li></ul></td></tr><tr><th>Pathways</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>SNP Mediated Effects</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>SNP Mediated Adverse Drug Reactions</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="admet"><th class="divider" colspan="2">ADMET</th></tr><tr><th>Predicted ADMET features</th><td class="data-table-container"><table class="table table-condensed table-striped" id="predicted-admet">
  <thead>
    <tr>
      <th>Property</th>
      <th>Value</th>
      <th>Probability</th>
    </tr>
  </thead>
  <tbody>
      <tr>
        <td>Human Intestinal Absorption</td>
        <td>
              +
        </td>
        <td>0.9958</td>
      </tr>
      <tr>
        <td>Blood Brain Barrier</td>
        <td>
              -
        </td>
        <td>0.6467</td>
      </tr>
      <tr>
        <td>Caco-2 permeable</td>
        <td>
              +
        </td>
        <td>0.8867</td>
      </tr>
      <tr>
        <td>P-glycoprotein substrate</td>
        <td>
            Substrate
        </td>
        <td>0.8522</td>
      </tr>
      <tr>
        <td>P-glycoprotein inhibitor I</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.6567</td>
      </tr>
      <tr>
        <td>P-glycoprotein inhibitor II</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.9552</td>
      </tr>
      <tr>
        <td>Renal organic cation transporter</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.9105</td>
      </tr>
      <tr>
        <td>CYP450 2C9 substrate</td>
        <td>Non-substrate</td>
        <td>0.7898</td>
      </tr>
      <tr>
        <td>CYP450 2D6 substrate</td>
        <td>Substrate</td>
        <td>0.8918</td>
      </tr>
      <tr>
        <td>CYP450 3A4 substrate</td>
        <td>Substrate</td>
        <td>0.5389</td>
      </tr>
      <tr>
        <td>CYP450 1A2 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9046</td>
      </tr>
      <tr>
        <td>CYP450 2C9 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9071</td>
      </tr>
      <tr>
        <td>CYP450 2D6 substrate</td>
        <td>Inhibitor</td>
        <td>0.8932</td>
      </tr>
      <tr>
        <td>CYP450 2C19 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9026</td>
      </tr>
      <tr>
        <td>CYP450 3A4 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.8309</td>
      </tr>
      <tr>
        <td>CYP450 inhibitory promiscuity</td>
        <td>Low CYP Inhibitory Promiscuity</td>
        <td>0.8678</td>
      </tr>
      <tr>
        <td>Ames test</td>
        <td>
          Non AMES toxic 
        </td>
        <td>
            0.9132
        </td>
      </tr>
      <tr>
        <td>Carcinogenicity</td>
        <td>
          Non-carcinogens 
        </td>
        <td>
            0.7338
        </td>
      </tr>
      <tr>
        <td>Biodegradation</td>
        <td>
          Not ready biodegradable 
        </td>
        <td>
            1.0
        </td>
      </tr>
      <tr>
        <td>Rat acute toxicity</td>
        <td>
          2.6096 
            LD50, mol/kg
        </td>
        <td>
            <span class="wishart wishart-not-available">Not applicable</span>
        </td>
      </tr>
      <tr>
        <td>hERG inhibition (predictor I)</td>
        <td>
          Weak inhibitor 
        </td>
        <td>
            0.9214
        </td>
      </tr>
      <tr>
        <td>hERG inhibition (predictor II)</td>
        <td>
          Non-inhibitor 
        </td>
        <td>
            0.7334
        </td>
      </tr>
  </tbody>
</table>
</td></tr><tr id="pharmacoeconomics"><th class="divider" colspan="2">Pharmacoeconomics</th></tr><tr><th>Manufacturers</th><td><ul><li>Santen oy</li>
<li>Falcon pharmaceuticals ltd</li>
<li>Aton pharma inc</li>
<li>Ista pharmaceuticals</li>
<li>Akorn inc</li>
<li>Bausch and lomb pharmaceuticals inc</li>
<li>Bausch and lomb inc</li>
<li>Falcon pharmaceuticals inc</li>
<li>Fdc ltd</li>
<li>E fougera div altana inc</li>
<li>Hi tech pharmacal co inc</li>
<li>Novex pharma</li>
<li>Pacific pharma inc</li>
<li>Pacific pharma</li>
<li>Wockhardt ltd</li>
<li>Merck research laboratories div merck co inc</li>
<li>Mylan pharmaceuticals inc</li>
<li>Quantum pharmics ltd</li>
<li>Sandoz inc</li>
<li>Teva pharmaceuticals usa inc</li>
<li>Usl pharma inc</li>
<li>Watson laboratories inc</li></ul></td></tr><tr><th>Packagers</th><td><ul><li><a href="http://www.akorn.com">Akorn Inc.</a></li>
<li><a href="http://www.alcon.com">Alcon Laboratories</a></li>
<li><a href="http://www.allergan.com">Allergan Inc.</a></li>
<li><a href="http://www.apotex.com">Apotex Inc.</a></li>
<li><a href="http://orders.a-smeds.com">A-S Medication Solutions LLC</a></li>
<li><a href="http://www.atonrx.com">Aton Pharma Inc.</a></li>
<li><a href="http://www.bausch.com">Bausch &amp; Lomb Inc.</a></li>
<li><a href="http://www.drxdispensing.com">Dispensing Solutions</a></li>
<li><a href="http://www.fougera.com">E. Fougera and Co.</a></li>
<li><a href="http://www.endo.com">Endo Pharmaceuticals Inc.</a></li>
<li><a href="http://www.falconpharma.com">Falcon Pharmaceuticals Ltd.</a></li>
<li><a href="http://www.hitechpharm.com">Hi Tech Pharmacal Co. Inc.</a></li>
<li><a href="http://www.istavision.com">ISTA Pharmaceuticals</a></li>
<li><a href="http://www.majorpharmaceuticals.com">Major Pharmaceuticals</a></li>
<li><a href="http://www.medisca.com">Medisca Inc.</a></li>
<li><a href="http://www.merck.com">Merck &amp; Co.</a></li>
<li><a href="http://www.unitdosesupply.com">Murfreesboro Pharmaceutical Nursing Supply</a></li>
<li><a href="http://www.mylan.com">Mylan</a></li>
<li>Novex Pharma</li>
<li>Novopharm Ltd.</li>
<li>Pacific Pharma Lp</li>
<li><a href="http://www.packpharma.com">Pack Pharmaceuticals</a></li>
<li><a href="http://www.palmettopharm.com">Palmetto Pharmaceuticals Inc.</a></li>
<li>PCAS Finland Oy</li>
<li><a href="http://www.personandcovey.com">Person &amp; Covey</a></li>
<li><a href="http://www.pharmedixrx.com">Pharmedix</a></li>
<li><a href="http://www.physicianstotalcare.com">Physicians Total Care Inc.</a></li>
<li><a href="http://www.prasco.com">Prasco Labs</a></li>
<li><a href="http://www.worldoftest.com">Qualitest</a></li>
<li><a href="http://www.sandhillspackaging.com">Sandhills Packaging Inc.</a></li>
<li><a href="http://www.sandoz.ca">Sandoz</a></li>
<li><a href="http://www.santeninc.com">Santen Inc.</a></li>
<li><a href="http://vistakonpharmaceutical.com">Vistakon Pharmaceuticals LLC</a></li></ul></td></tr><tr><th>Dosage forms</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="dosages"><thead><tr><th>Form</th><th>Route</th><th>Strength</th></tr></thead><tbody><tr><td>Liquid</td><td>Ophthalmic</td><td></td></tr><tr><td>Solution</td><td>Ophthalmic</td><td></td></tr><tr><td>Solution / drops</td><td>Ophthalmic</td><td></td></tr><tr><td>Tablet</td><td>Oral</td><td></td></tr></tbody></table></td></tr><tr id="spectra"><th class="divider" colspan="2">Spectra</th></tr><tr><th>Spectra</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="interactions"><th class="divider" colspan="2">Interactions</th></tr><tr><th>Drug Interactions</th><td class="data-table-container"><table class="table table-condensed table-striped" id="experimental-properties"><thead><tr><th>Drug</th><th style="width: 75%"></th></tr></thead><tbody><tr><td><a href="/drugs/DB00414">Acetohexamide</a></td><td>The beta-blocker, timolol, may decrease symptoms of hypoglycemia.</td></tr><tr><td><a href="/drugs/DB01223">Aminophylline</a></td><td>Antagonism of action and increased effect of theophylline</td></tr><tr><td><a href="/drugs/DB00482">Celecoxib</a></td><td>The NSAID, Celecoxib, may antagonize the antihypertensive effect of Timolol.</td></tr><tr><td><a href="/drugs/DB00672">Chlorpropamide</a></td><td>The beta-blocker, timolol, may decrease symptoms of hypoglycemia.</td></tr><tr><td><a href="/drugs/DB00501">Cimetidine</a></td><td>Cimetidine may increase the serum concentration of timolol by decreasing its metabolism.</td></tr><tr><td><a href="/drugs/DB00575">Clonidine</a></td><td>Increased hypertension when clonidine stopped</td></tr><tr><td><a href="/drugs/DB00586">Diclofenac</a></td><td>The NSAID, Diclofenac, may antagonize the antihypertensive effect of Timolol.</td></tr><tr><td><a href="/drugs/DB00861">Diflunisal</a></td><td>The NSAID, Diflunisal, may antagonize the antihypertensive effect of Timolol.</td></tr><tr><td><a href="/drugs/DB00320">Dihydroergotamine</a></td><td>Ischemia with risk of gangrene</td></tr><tr><td><a href="/drugs/DB00343">Diltiazem</a></td><td>Additive effects of decreased heart rate and contractility may occur. Increased risk of heart block. </td></tr><tr><td><a href="/drugs/DB00280">Disopyramide</a></td><td>The beta-blocker, timolol, may increase the toxicity of disopyramide.</td></tr><tr><td><a href="/drugs/DB00651">Dyphylline</a></td><td>Antagonism of action and increased effect of theophylline</td></tr><tr><td><a href="/drugs/DB00668">Epinephrine</a></td><td>Hypertension, then bradycardia</td></tr><tr><td><a href="/drugs/DB01253">Ergonovine</a></td><td>Ischemia with risk of gangrene</td></tr><tr><td><a href="/drugs/DB00696">Ergotamine</a></td><td>Ischemia with risk of gangrene</td></tr><tr><td><a href="/drugs/DB00749">Etodolac</a></td><td>The NSAID, Etodolac, may antagonize the antihypertensive effect of Timolol.</td></tr><tr><td><a href="/drugs/DB00573">Fenoprofen</a></td><td>The NSAID, Fenoprofen, may antagonize the antihypertensive effect of Timolol.</td></tr><tr><td><a href="/drugs/DB01288">Fenoterol</a></td><td>Antagonism</td></tr><tr><td><a href="/drugs/DB00712">Flurbiprofen</a></td><td>The NSAID, Flurbiprofen, may antagonize the antihypertensive effect of Timolol.</td></tr><tr><td><a href="/drugs/DB00983">Formoterol</a></td><td>Antagonism</td></tr><tr><td><a href="/drugs/DB01120">Gliclazide</a></td><td>The beta-blocker, timolol, may decrease symptoms of hypoglycemia.</td></tr><tr><td><a href="/drugs/DB01067">Glipizide</a></td><td>The beta-blocker, timolol, may decrease symptoms of hypoglycemia.</td></tr><tr><td><a href="/drugs/DB01289">Glisoxepide</a></td><td>The beta-blocker, timolol, may decrease symptoms of hypoglycemia.</td></tr><tr><td><a href="/drugs/DB01016">Glyburide</a></td><td>The beta-blocker, timolol, may decrease symptoms of hypoglycemia.</td></tr><tr><td><a href="/drugs/DB01382">Glycodiazine</a></td><td>The beta-blocker, timolol, may decrease symptoms of hypoglycemia.</td></tr><tr><td><a href="/drugs/DB00328">Indomethacin</a></td><td>Risk of inhibition of renal prostaglandins</td></tr><tr><td><a href="/drugs/DB00047">Insulin Glargine</a></td><td>The beta-blocker, timolol, may decrease symptoms of hypoglycemia.</td></tr><tr><td><a href="/drugs/DB05334">insulin inhaled</a></td><td>The beta-blocker, timolol, may decrease symptoms of hypoglycemia.</td></tr><tr><td><a href="/drugs/DB01064">Isoprenaline</a></td><td>Antagonism</td></tr><tr><td><a href="/drugs/DB01009">Ketoprofen</a></td><td>The NSAID, Ketoprofen, may antagonize the antihypertensive effect of Timolol.</td></tr><tr><td><a href="/drugs/DB00465">Ketorolac</a></td><td>The NSAID, Ketorolac, may antagonize the antihypertensive effect of Timolol.</td></tr><tr><td><a href="/drugs/DB00281">Lidocaine</a></td><td>The beta-blocker, timolol, may increase the effect and toxicity of lidocaine.</td></tr><tr><td><a href="/drugs/DB01283">Lumiracoxib</a></td><td>The NSAID, Lumiracoxib, may antagonize the antihypertensive effect of Timolol.</td></tr><tr><td><a href="/drugs/DB00939">Meclofenamic acid</a></td><td>The NSAID, Meclofenamate, may antagonize the antihypertensive effect of Timolol.</td></tr><tr><td><a href="/drugs/DB00814">Meloxicam</a></td><td>The NSAID, Meloxicam, may antagonize the antihypertensive effect of Timolol.</td></tr><tr><td><a href="/drugs/DB00968">Methyldopa</a></td><td>Possible hypertensive crisis</td></tr><tr><td><a href="/drugs/DB00247">Methysergide</a></td><td>Ischemia with risk of gangrene</td></tr><tr><td><a href="/drugs/DB00461">Nabumetone</a></td><td>The NSAID, Nabumetone, may antagonize the antihypertensive effect of Timolol.</td></tr><tr><td><a href="/drugs/DB00788">Naproxen</a></td><td>The NSAID, Naproxen, may antagonize the antihypertensive effect of Timolol.</td></tr><tr><td><a href="/drugs/DB00816">Orciprenaline</a></td><td>Antagonism</td></tr><tr><td><a href="/drugs/DB00991">Oxaprozin</a></td><td>The NSAID, Oxaprozin, may antagonize the antihypertensive effect of Timolol.</td></tr><tr><td><a href="/drugs/DB01303">Oxtriphylline</a></td><td>Antagonism of action and increased effect of theophylline</td></tr><tr><td><a href="/drugs/DB00236">Pipobroman</a></td><td>Antagonism</td></tr><tr><td><a href="/drugs/DB01291">Pirbuterol</a></td><td>Antagonism</td></tr><tr><td><a href="/drugs/DB00554">Piroxicam</a></td><td>Risk of inhibition of renal prostaglandins</td></tr><tr><td><a href="/drugs/DB00457">Prazosin</a></td><td>Risk of hypotension at the beginning of therapy</td></tr><tr><td><a href="/drugs/DB01366">Procaterol</a></td><td>Antagonism</td></tr><tr><td><a href="/drugs/DB00912">Repaglinide</a></td><td>The beta-blocker, timolol, may decrease symptoms of hypoglycemia.</td></tr><tr><td><a href="/drugs/DB01001">Salbutamol</a></td><td>Antagonism</td></tr><tr><td><a href="/drugs/DB00938">Salmeterol</a></td><td>Antagonism</td></tr><tr><td><a href="/drugs/DB00605">Sulindac</a></td><td>The NSAID, Sulindac, may antagonize the antihypertensive effect of Timolol.</td></tr><tr><td><a href="/drugs/DB01162">Terazosin</a></td><td>Increased risk of hypotension. Initiate concomitant therapy cautiously.</td></tr><tr><td><a href="/drugs/DB00857">Terbinafine</a></td><td>Terbinafine may reduce the metabolism and clearance of Timolol. Consider alternate therapy or monitor for therapeutic/adverse effects of Amytriptyline if Timolol is initiated, discontinued or dose changed.</td></tr><tr><td><a href="/drugs/DB00871">Terbutaline</a></td><td>Antagonism</td></tr><tr><td><a href="/drugs/DB00277">Theophylline</a></td><td>Antagonism of action and increased effect of theophylline</td></tr><tr><td><a href="/drugs/DB01600">Tiaprofenic acid</a></td><td>The NSAID, Tiaprofenic acid, may antagonize the antihypertensive effect of Timolol.</td></tr><tr><td><a href="/drugs/DB00839">Tolazamide</a></td><td>The beta-blocker, timolol, may decrease symptoms of hypoglycemia.</td></tr><tr><td><a href="/drugs/DB01124">Tolbutamide</a></td><td>The beta-blocker, timolol, may decrease symptoms of hypoglycemia.</td></tr><tr><td><a href="/drugs/DB00500">Tolmetin</a></td><td>The NSAID, Tolmetin, may antagonize the antihypertensive effect of Timolol.</td></tr><tr><td><a href="/drugs/DB00374">Treprostinil</a></td><td>Additive hypotensive effect. Monitor antihypertensive therapy during concomitant use. </td></tr><tr><td><a href="/drugs/DB00661">Verapamil</a></td><td>Additive effects of decreased heart rate and contractility may occur. Increased risk of heart block. </td></tr></tbody></table></td></tr><tr><th>Food Interactions</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr></tbody></table>